Page last updated: 2024-12-06

moniliformin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Moniliformin is a mycotoxin produced by several Fusarium species, commonly found in cereals such as corn, wheat, and rice. It is a potent inhibitor of the mitochondrial enzyme aconitase, which plays a crucial role in the citric acid cycle. This inhibition leads to the disruption of cellular energy production and can cause various adverse effects in humans and animals. Moniliformin is of significant concern due to its potential toxicity, particularly in livestock, where it can cause growth retardation, liver damage, and other health issues. Studies on moniliformin are essential to understand its occurrence, mechanisms of action, and potential risks to human and animal health. This knowledge is crucial for developing effective strategies to mitigate moniliformin contamination in food and feed.'

moniliformin: RN given refers to parent cpd; structure; do not confuse with plant product, moniliformin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID40452
CHEMBL ID1977616
MeSH IDM0052477

Synonyms (34)

Synonym
moniliformin
NSC292896 ,
NCI60_002420
hydroxycyclobutenedione
brn 1925339
nsc 292896
ccris 4943
1-hydroxycyclobut-1-ene-3,4-dione
1-hydroxy-cyclobut-1-ene-3,4-dione
3-hydroxy-3-cyclobutene-1,2-dione
3-hydroxy-3-cyclobutenedione
cyclobutenedione, hydroxy-
semisquaric acid
3-cyclobutene-1,2-dione, 3-hydroxy-
31876-38-7
nsc-292896
3-hydroxycyclobut-3-ene-1,2-dione
AKOS006278733
3-hydroxy-cyclobut-3-ene-1,2-dione
g5jmq8sdf8 ,
unii-g5jmq8sdf8
1-hydroxycyclobutene-3,4-dione
C20592
39284-13-4
KGPQKNJSZNXOPV-UHFFFAOYSA-N
CHEMBL1977616
DTXSID10185731
J-018558
1345994-72-0
CS-B1622
Q904389
monoliformin 100 microg/ml in acetonitrile
EN300-92006
4-hydroxy-3-cyclobutene-1,2-dione-1,4-13c2

Research Excerpts

Overview

Moniliformin (MON) is a widely occurring mycotoxin, produced mainly by Fusarium proliferatum and Fus aquarium subglutinans in corn. It has been shown to be acutely toxic for various animal species and is a suspected cause of Keshan disease in China.

ExcerptReferenceRelevance
"Moniliformin is a Fusarium mycotoxin mainly produced by several species infecting grains in different climatic conditions. "( Repeated dose 28-day oral toxicity study of moniliformin in rats.
Anttila, M; Atosuo, J; Jestoi, M; Jonsson, M; Koivisto, P; Kokkonen, UM; Lilius, EM; Nathanail, AV; Peltonen, K, 2015
)
2.12
"Moniliformin is a mycotoxin produced by several cereal associated Fusaria. "( Production of the Fusarium Mycotoxin Moniliformin by Penicillium melanoconidium.
Frisvad, JC; Hallas-Møller, M; Nielsen, KF, 2016
)
2.15
"Moniliformin is a mycotoxin produced by fungi of the Fusarium genus and occurs as a contaminant of different cereals worldwide. "( Analysis of the Fusarium mycotoxin moniliformin in cereal samples using 13C2-moniliformin and high-resolution mass spectrometry.
Cramer, B; Humpf, HU; Lohrey, L; von Bargen, KW, 2012
)
2.1
"Moniliformin is a Fusarium mycotoxin highly prevalent in grains and grain-based products worldwide. "( Application of OECD Guideline 423 in assessing the acute oral toxicity of moniliformin.
Anttila, M; Jestoi, M; Jonsson, M; Karhunen, P; Koivisto, P; Kokkonen, UM; Nathanail, AV; Peltonen, K, 2013
)
2.06
"Moniliformin is a mycotoxin produced by certain fungi pathogenic to maize. "( Detection of moniliformin in maize using capillary zone electrophoresis.
Maragos, CM, 2004
)
2.14
"Moniliformin is a low molecular weight mycotoxin that has worldwide potential to contaminate cereal grains. "( Synthesis and evaluation of molecularly imprinted polymers as sorbents of moniliformin.
Appell, M; Kendra, DF; Kim, EK; Maragos, CM, 2007
)
2.01
"Moniliformin (MON) is a widely occurring mycotoxin, produced mainly by Fusarium proliferatum and Fusarium subglutinans in corn, that has been shown to be acutely toxic for various animal species and is a suspected cause of Keshan disease in China. "( Thermal stability of moniliformin at varying temperature, pH, and time in an aqueous environment.
Bullerman, LB; Pineda-Valdes, G, 2000
)
2.07
"Moniliformin is a mycotoxin produced by Fusarium subglutinans and other Fusarium species. "( Liquid chromatographic determination and stability of the Fusarium mycotoxin moniliformin in cereal grains.
Lawrence, GA; Scott, PM,
)
1.8

Toxicity

The LD50 of purified moniliformin upon intravenous injection of 7-week-old female broiler chickens was 1. Isolates that caused the death of 3 or 4 out of 4 ducklings were considered to be toxic. According to our study, monilominin is acutely toxic to rats with a rather narrow range of toxicity.

ExcerptReferenceRelevance
" The intravenous LD50 of MLFN in mice was found to be 17."( [Toxic effects of moniliformin on heart function in rats].
Sun, L, 1990
)
0.61
" Isolates that caused the death of 3 or 4 out of 4 ducklings were considered to be toxic and analyzed for moniliformin."( Toxicity and moniliformin production by four recently described species of Fusarium and two uncertain taxa.
Lübben, A; Marasas, WF; Nelson, PE; Rabie, CJ; Sydenham, EW; Thiel, PG, 1991
)
0.86
" Zearalenone was about 3 times more toxic than its analogue zearalenol."( Toxicity of trichothecenes, moniliformin, zearalenone/ol, griseofulvin, patulin, PR toxin and rubratoxin B on protozoan tetrahymena pyriformis.
Cole, RJ; Cutler, HG; Nishie, K, 1989
)
0.57
" FB1 was not toxic to macrophages, hepatocytes, cardiac and skeletal myocytes but toxic to splenocytes and chondrocytes."( Comparative cytotoxicity of fumonisin B1 and moniliformin in chicken primary cell cultures.
Liu, T; Vesonder, RF; Wu, W, 1995
)
0.55
" According to our study, moniliformin is acutely toxic to rats with a rather narrow range of toxicity."( Application of OECD Guideline 423 in assessing the acute oral toxicity of moniliformin.
Anttila, M; Jestoi, M; Jonsson, M; Karhunen, P; Koivisto, P; Kokkonen, UM; Nathanail, AV; Peltonen, K, 2013
)
0.92

Bioavailability

ExcerptReferenceRelevance
" Some studies suggest that esterified glucomannan derived from the cell wall of Saccharomyces cerevisiae is effective in reducing the bioavailability of at least some of the mycotoxins occurring in contaminated feed."( Efficacy of a commercial mycotoxin binder in alleviating effects of ochratoxin A, fumonisin B1, moniliformin and zearalenone in adult mink.
Bursian, SJ; Choi, I; Fernadez, G; Fernandez, G; Fitzgerald, SD; Leefers, K; Mitchell, RR; Moran, L; Murphy, PA; Rottinghaus, GE; Yamini, B, 2004
)
0.54

Dosage Studied

The experiment of toxicity comparison between moniliformin and its analogous material squaric acid was made using one-day age Beijing Ducklings by oral applying both medicines at dosage of 8mg/kg and 24 mg/kg body weight separately. The various concentrations of FB1 and monilathan in the amended rations produced well-defined dose-response lesions in all groups in all four trials.

ExcerptRelevanceReference
" Mice were given moniliformin orally at the dosage of 29."( [Ultrastructural study of moniliformin-induced lesions on the myocardium of rats and mice].
Zhao, D, 1990
)
0.92
" Toxicity may be alleviated to certain extent by applying adequate dosage of Selenium (3."( [Study on toxicological mechanism of moniliformin].
Li, JL; Zhang, H, 1989
)
0.55
" The experiment of toxicity comparison between moniliformin and its analogous material squaric acid was made using one-day age Beijing Ducklings by oral applying both medicines at dosage of 8mg/kg and 24mg/kg body weight separately."( [Detoxification of moniliformin].
Li, J; Zhang, H, 1994
)
0.87
" Rats were given moniliformin orally at the dosage of 6 mg."( Ultrastructural study of moniliformin induced lesions of myocardium in rats and mice.
Cui, Q; Feng, Q; Li, C; Pan, Y; Yan, X; Zhao, D, 1993
)
0.93
" All three mycotoxins caused moderate increases of the MN frequencies at low concentrations (< or = 1 microgram/ml), but no clear dose-response effects were seen and at higher exposure levels the MN frequencies declined."( Genotoxic effects of three Fusarium mycotoxins, fumonisin B1, moniliformin and vomitoxin in bacteria and in primary cultures of rat hepatocytes.
Bresgen, N; Eckl, PM; Gelderblom, W; Kassie, F; Knasmüller, S; Mersch-Sundermann, V; Zöhrer, E, 1997
)
0.54
" The various concentrations of FB1 and moniliformin in the amended rations produced well-defined dose-response lesions in all groups in all four trials."( Comparative pathologic changes in broiler chicks on feed amended with Fusarium proliferatum culture material or purified fumonisin B1 and moniliformin.
Bennett, GA; Buck, WB; Bunte, RM; Côté, LM; Dombrink-Kurtzman, MA; Javed, T; Richard, JL, 2005
)
0.8
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (145)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (11.72)18.7374
1990's46 (31.72)18.2507
2000's43 (29.66)29.6817
2010's33 (22.76)24.3611
2020's6 (4.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.02

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.02 (24.57)
Research Supply Index5.11 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index36.71 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.02)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (1.23%)5.53%
Reviews8 (4.94%)6.00%
Case Studies1 (0.62%)4.05%
Observational0 (0.00%)0.25%
Other151 (93.21%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]